PHASE 1 STUDY RESULTS OF M7824 (MSB0011359C), A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF- AND PD-L1, AMONG PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Khasraw, M; Weller, M; Estelles, DL; Kolibaba, K; Lee, C; Gedye, C; De La Fuente, M; Vicente, D; Reardon, D; Ojalvo, L; Helwig, C; Gourmelon, C; Groves, M

Published Date

  • November 1, 2018

Published In

Volume / Issue

  • 20 /

Start / End Page

  • 4 - 4

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1523-5866

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • 23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference

Conference Location

  • New Orleans, LA

Conference Start Date

  • November 14, 2018

Conference End Date

  • November 18, 2018